Home/BlackfinBio/Peter Nolan

PN

Peter Nolan

Founder, Chief and Interim CEO

Therapeutic Areas

Central Nervous System (CNS) Diseases Rare Neurological Diseases Neurodegenerative Diseases

BlackfinBio Pipeline

Drug	Indication	Phase
Lead Program (undisclosed)	Rare Neurological Disease (CNS)	Pre-clinical

Leadership Team at BlackfinBio

Prof. Mimoun Azzouz

Scientific Founder (University of Sheffield)

View full BlackfinBio profile